等待开盘 02-04 09:30:00 美东时间
+0.019
+0.66%
Tilray shares are flat Thursday morning as the company prepares to report its fiscal second-quarter 2026 results after the bell, stirring investor interest.
01-09 01:41
Cannabis companies were among notable underperformers on Thursday, as Wall Street was awaiting an executive order from President Donald Trump that would classify marijuana as a less dangerous drug. ...
2025-12-19 02:55
Rep. Mike Lawler (R-N.Y.) wants President Trump to think again about potentially rescheduling marijuana to a less harmful drug, calling cannabis a "gateway drug." "Most of the people who end up using ...
2025-12-17 04:04
Major cannabis ETFs recorded their best-ever weekly gains on Friday after media reports indicated that President Donald Trump will soon issue an executive order to reclassify marijuana as a less dange...
2025-12-14 02:22
Cannabis ETFs regain momentum as President Trump considers reclassifying marijuana to Schedule III.
2025-12-13 03:29
Cannabis stock extended premarket gains in regular trading on Friday after CNBC reported that President Donald Trump is expected to sign his much-anticipated executive order to reclassify marijuana as...
2025-12-13 00:25
Cannabis producer stocks popped in U.S. premarket trading on Friday on multiple media reports that President Donald Trump is expected to push for reclassifying marijuana as a less dangerous drug. Top ...
2025-12-12 19:24
Tilray slips despite unveiling a licensed Panama JV to expand its medical cannabis footprint and clinician-focused access.
2025-10-14 23:45
Wall Street will be keenly watching the performance of cannabis stocks on Thursday after Tilray Brands (NASDAQ:TLRY) posted its first revenue beat in four quarters and shares of the Canadian marijuana...
2025-10-09 19:54